Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil… — Class II drug recall D-0523-2020
Terminated recall by New Vitalis Pharmacy LLC dba New Vitalis Pharmacy, reported 2019-12-04, distributed nationwide. Lack of sterility assurance.
| Recall number | D-0523-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | New Vitalis Pharmacy LLC dba New Vitalis Pharmacy, Louisville, KY, United States |
| Recall initiated | 2019-10-01 |
| Classified | 2019-11-25 |
| Reported by FDA | 2019-12-04 |
| Terminated | 2023-03-09 |
| Distributed | Nationwide (US) |
| Quantity | 2,981.62 ml |
| Reason classes | sterility |
| Expiration dates | 2019-09-23, 2019-09-30, 2019-10-13, 2019-10-27, 2019-10-28, 2019-11-03 |
Product
Testosterone Cypionate 180 mg/mL/Testosterone Propionate 20mg/mL Oil Injection Solution, 10 mL per vial, New Vitalis Pharmacy
Reason for recall
Lack of sterility assurance.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0523-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.